Sector: Pharmaceuticals & Biotechnology

Mid Cap

Senores Pharmaceuticals Share Price

SENORES

₹1,566

52.70(3.48%)

24th Aug 2026 | 11:40 AM

NSE : SENORES

Open Free Demat Account

Senores Pharmaceuticals Performance

Price Movement

₹1566.00

₹1520.90

₹1599.00

↘ Today's Low↗ Today's High

1 Year Performance

₹1566.00

₹662.45

₹1577.50

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,599.00

Low₹1,520.90

Open at₹1,521.00

Prev Close₹1,513.30

Volumes2.23 L

Avg Price₹1,572.42

Lower Circuit₹1,210.70

Upper Circuit₹1,815.90

Historical Performance

3M High₹1,577.50

3M Low₹1,001.00

1 Yr High₹1,577.50

1 Yr Low₹662.45

3 Yr High₹1,577.50

3 Yr Low₹435.25

5 Yr High₹1,577.50

5 Yr Low₹435.25

Summary

As of 24-08-2026 12:01, Senores Pharmaceuticals Ltd. share price today is ₹0, with a change of ₹-1513.30 (-100.00%) from the previous close of ₹1513.3. The stock opened at ₹1521 and traded between ₹1520.9 and ₹1599, with a total traded volume of 222608 shares. The company has a market capitalization of ₹7142.5 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹1577.5 and ₹662.45, respectively.

Senores Pharmaceuticals Ltd. valuation metrics include a P/E ratio of 56.5, EPS of ₹26.39, and book value of ₹7.70. Profitability indicators show ROE of 12.35%. Senores Pharmaceuticals Ltd. has reported revenue of ₹691.72 Cr and net profit of ₹126.37 Cr.

Senores Pharmaceuticals Ltd. technical indicators include Day RSI at 70.19, Day MFI at 82.76, Day ADX at 27.59. Additional indicators include Commodity Channel Index (CCI) at 137.8 and Williams %R at -9.37. Momentum indicators show Day MACD at 51.38, Day MACD Signal Line at 35.23, DayATR at 56.07. Rate of Change indicators for Senores Pharmaceuticals Ltd. include ROC125 at 97.93 and ROC21 at 10.46.

Exponential moving averages include EMA5 at ₹1520.4, EMA10 at ₹1480.8, EMA12 at ₹1469.2, EMA20 at ₹1436.8, EMA26 at ₹1417.8, EMA50 at ₹1342.3, EMA100 at ₹1205.1, EMA200 at ₹1034.4. Simple moving averages include SMA5 at ₹1520.6, SMA10 at ₹1466.5, SMA20 at ₹1407, SMA30 at ₹1412.8, SMA50 at ₹1366.6, SMA100 at ₹1153.4, SMA150 at ₹1030.6, SMA200 at ₹972.9.

Support levels for Senores Pharmaceuticals are placed at First Support ₹1526.03, Second Support ₹1501.17, Third Support ₹1475.43. Resistance levels are seen at First Resistance ₹1576.63, Second Resistance ₹1602.37, Third Resistance ₹1627.23. Senores Pharmaceuticals Ltd. shareholding pattern shows promoter holding at 45.82%, FII holding at 6.62%, DII holding at 0%, public holding at 37.78%.

Senores Pharmaceuticals Fundamentals

Market Cap

Above industry Median

7,142.50 Cr.

PE Ratio (TTM)

High in industry

56.50

Dividend Yield

Net Profit TTM

87.0% incr over last year

126.37

Net Profit Growth

87.0% incr over last year

126.37

PEG Ratio

Above industry Median

0.60

ROE

66.0% incr over last year

12.35

Operating Revenue TTM

691.72

Operating Revenue Growth

51.7% incr over last year

Book Value

High in industry

7.70

MFI

MFI strongly Overbought

82.76

RSI

RSI Overbought

70.19

EPS (TTM)

26.39

Debt to Equity

0.35

Face Value

Operating Profit Margin Qtr.

24.76

Operating Profit Qtr.

53.76

Net Profit Qtr.

30.72

Operating Revenue Qtr.

180.21

PB Ratio

7.70

Senores Pharmaceuticals Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Total Revenue	26.99	36.81	28.76	35.33	19.82
Operating Expense	29.32	40.29	29.69	33.81	20.97
Operating Profit	-2.33	-3.48	-0.93	1.52	-1.15
Depreciation	3.61	4.13	3.58	3.65	1.88
Interest	2.22	1.89	1.75	1.58	1.76
Tax	0.36	4.21	0.87	1.22	0.90
Net Profit	1.03	8.48	2.65	6.43	2.70

Senores Pharmaceuticals Technicals

Senores Pharmaceuticals Ltd. EMA & SMA

₹1566.00

28.50 (1.85%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1520.4

Day EMA10 ₹1480.8

Day EMA12 ₹1469.2

Day EMA20 ₹1436.8

Day EMA26 ₹1417.8

Day EMA50 ₹1342.3

Day EMA100 ₹1205.1

Day EMA200 ₹1034.4

Senores Pharmaceuticals Support and Resistance

Resistance

First Resistance₹1576.63

Second Resistance₹1602.37

Third Resistance₹1627.23

Support

First Support₹1526.03

Second Support₹1501.17

Third Support₹1475.43

Technical Indicators

Day RSI70.19

Day MFI82.76

Day ADX27.59

Day Commodity Channel Index137.80

William-9.37

Day MACD51.38

Day MACD Signal Line35.23

Day ATR56.07

Day ROC12597.93

Day ROC2110.46

Senores Pharmaceuticals Shareholding Pattern

Held By	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoter	45.8	45.8	45.8	45.8	45.8	45.8
FII	4.2	3.7	4.3	3.4	3.6	6.6
DII	9.6	9.5	8.6	9.3	9.7	9.8
Public	40.4	41	41.3	41.5	40.9	37.8

Senores Pharmaceuticals Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	54.67 K	1.73 L	31.55%
Week	88.85 K	2.09 L	42.53%
1 Month	1.27 L	3.04 L	41.79%
6 Month	1.52 L	3.65 L	41.59%

Senores Pharmaceuticals SWOT Analysis

Strengths34

Weakness9

Opportunity5

Threats0

Benjamin Graham Value Screen

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Expensive Stars (DVM)

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Companies with high TTM EPS Growth

Growth Stars: Strongest Annual EPS Performers

Stringent DVM Screener

Weekly Screener: High Momentum Score Stocks (subscription)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Stocks gaining versus previous close, open price and RSI

New 52 week high today

High Momentum Scores (Technical Scores greater than 50)

Good quarterly growth in the recent results

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Increasing Revenue every Quarter for the past 8 Quarters

Effectively using its capital to generate profit - RoCE improving in last 2 years

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing Revenue every Quarter for the past 4 Quarters

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Highest Recovery from 52 Week Low

RSI indicating price strength

Top Gainers

New 52 Week High

Stocks near 52 Week High with Significant Volumes

Insiders bought stocks

Stocks Outperforming their Industry Price Change in the Quarter

Senores Pharmaceuticals Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Senores Pharmaceuticals Stock Comparison

Financials	Corona Remedies Ltd.	Sudeep Pharma Ltd.	OneSource Specialty Pharma Ltd.	Sanofi Consumer Healthcare India Ltd.	Akums Drugs & Pharmaceuticals Ltd.
Price (₹)	₹2,158.70	₹1,125.85	₹1,527	₹4,190.20	₹774.50
% Change	0.75%	1.26%	-0.52%	-0.76%	3.27%
Revenue TTM (₹ Cr)	₹1,479.07	₹675.61	₹1,543.34	₹949.80	₹4,501.61
Net Profit TTM (₹ Cr)	₹199.03	₹182.64	₹-48.62	₹266	₹291.72
PE TTM	65.20	71.50	-358.60	36.60	40.60
1 Year Return	99.76	95.01	-17.12	-19	57.13
ROCE	31.54	24.22	0.59	-	11.40

Similar Stocks

INNOVACAP

Innova Captab Ltd.

₹ 1078.70

-0.90%

BLUEJET

Blue Jet Healthcare Ltd

₹ 605.00

+1.48%

CONCORDBIO

Concord Biotech Ltd.

₹ 1536.20

-2.23%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 843.00

+3.21%

SUPRIYA

Supriya Lifescience Ltd.

₹ 803.80

-0.20%

ALIVUS

Alivus Life Sciences Ltd.

₹ 1346.60

-0.32%

COHANCE

Cohance Lifesciences Ltd.

₹ 452.20

-2.33%

ERIS

Eris Lifesciences Ltd.

₹ 1313.80

-1.08%

SYNGENE

Syngene International Ltd.

₹ 401.30

-1.46%

APLLTD

Alembic Pharmaceuticals Ltd.

₹ 815.00

-0.82%

SPARC

Sun Pharma Advanced Research Company Ltd.

₹ 197.07

+0.18%

STAR

Strides Pharma Science Ltd.

₹ 981.30

-0.50%

FDC

FDC Ltd.

₹ 348.40

-0.06%

SHILPAMED

Shilpa Medicare Ltd.

₹ 862.35

+5.82%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 891.55

+1.27%

NATCOPHARM

Natco Pharma Ltd.

₹ 885.00

+0.29%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 2500.00

-2.37%

MARKSANS

Marksans Pharma Ltd.

₹ 322.60

+0.40%

ORCHPHARMA

Orchid Pharma Ltd.

₹ 1020.50

+1.84%

VIYASH

Viyash Scientific Ltd.

₹ 268.60

-2.66%

ASTRAZEN

AstraZeneca Pharma India Ltd.

₹ 7265.00

-2.03%

BLISSGVS

Bliss GVS Pharma Ltd.

₹ 570.50

-1.49%

SANOFI

Sanofi India Ltd.

₹ 3315.00

-1.13%

MOREPENLAB

Morepen Laboratories Ltd.

₹ 96.40

+0.41%

PGHL

Procter & Gamble Health Ltd.

₹ 5869.00

+0.69%

FAQ's on SENORES

What is the current share price of Senores Pharmaceuticals Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Senores Pharmaceuticals Ltd. is ₹ 1566 on the NSE and ₹ 1565.3 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Senores Pharmaceuticals Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Senores Pharmaceuticals Ltd. is approximately ₹ 7142.5 Cr.

What are the PE and PB ratios for Senores Pharmaceuticals Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Senores Pharmaceuticals Ltd. is 56.5, and the Price-to-Book (PB) ratio is 7.7.

What is the 52-Week High and Low for Senores Pharmaceuticals Ltd.?

Over the past 52 weeks, the highest price reached by Senores Pharmaceuticals Ltd. shares was ₹ 1577.5, and the lowest price was ₹ 662.45.

Who are the major shareholders of Senores Pharmaceuticals Ltd.?

Significant shareholdings in Senores Pharmaceuticals Ltd. typically include entities such as:

Promoter
Public
FII
Mutual Funds
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Senores Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Senores Pharmaceuticals Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy